Clinical Trial Update: Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients [NA]

View source ↗

Summary

This clinical trial update describes the assessment of the PET imaging tracer [68Ga]Ga-PentixaFor for potential use in detecting metastatic disease in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• [68Ga]Ga-PentixaFor (pentixaFor radiopharmaceutical)

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Metastatic Breast Cancer | NA | Status: RECRUITING